Levofloxacin
A synthetic broad-spectrum fluoroquinolone antibiotic used to treat susceptible bacterial infections, including respiratory tract, urinary tract, skin and soft tissue infections. It exhibits bactericidal activity by inhibiting bacterial DNA gyrase and topoisomerase IV, thereby disrupting DNA replication and transcription. Levofloxacin is the pharmacologically active S-(-)-enantiomer of ofloxacin
CAS Number: 100986-85-4
Molecular Mass: 361.4 g/mol
Formula: C18H20FN3O4
Smiles: C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23
Synonymes:
Levofloxacin, LEVOFLOXACIN, 100986-85-4, Levaquin, Quixin, (-)-Ofloxacin, Iquix, Cravit, (S)-Ofloxacin, Levofloxacine, Tavanic, L-Ofloxacin, Levofloxacino, Levofloxacinum, Elequine, Oftaquix, Floxacin, Levofloxacin Anhydrous, DR-3355, Nofaxin, Volequin, Quinsair, NSC-758709, RIX4E89Y14, (S)-9-Fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7H-pyrido(1,2,3-de)-1,4-benzoxazine-6-carboxylic acid, DTXSID0041060, LEVAQUIN IN DEXTROSE 5% IN PLASTIC CONTAINER, RWJ-25213, CHEBI:63598, (2S)-7-fluoro-2-methyl-6-(4-methylpiperazin-1-yl)-10-oxo-4-oxa-1-azatricyclo[7.3.1.05,13]trideca-5(13),6,8,11-tetraene-11-carboxylic acid, (3S)-(-)-9-Fluoro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-2,3-dihydro-7H-pyrido[1,2,3-de][1,4]benzoxazine-6-carboxylic acid, 7H-Pyrido(1,2,3-de)-1,4-benzoxazine-6-carboxylic acid, 2,3-dihydro-9-fluoro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-, (S)-, (S)-(-)-9-fluoro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-2,3-dihydro-7H-pyrido[1,2,3-de][1,4]benzooxazine-6-carboxylic acid, Ofloxacin s-(-)-form hemihydrate, Anhydrous, Levofloxacin, lLevofloxacin, Evoxil, (2S)-7-fluoro-2-methyl-6-(4-methylpiperazin-1-yl)-10-oxo-4-oxa-1-azatricyclo(7.3.1.0^(5,13))trideca-5(13),6,8,11-tetraene-11-carboxylic acid, (2S)-7-fluoro-2-methyl-6-(4-methylpiperazin-1-yl)-10-oxo-4-oxa-1-azatricyclo(7.3.1.05,13)trideca-5(13),6,8,11-tetraene-11-carboxylic acid, (2S)-7-fluoro-2-methyl-6-(4-methylpiperazin-1-yl)-10-oxo-4-oxa-1-azatricyclo[7.3.1.0^{5,13}]trideca-5(13),6,8,11-tetraene-11-carboxylic acid, (3S)-(-)-9-Fluoro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-2,3-dihydro-7H-pyrido(1,2,3-de)(1,4)benzoxazine-6-carboxylic acid, (S)-(-)-9-Fluoro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-2,3-dihydro-7H-pyrido(1,2,3-de)(1,4)benzooxazine-6-carboxylic acid, Ofloxacin S-(-)-, RefChem:5945, (-)-(S)-9-Fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7H-pyrido(1,2,3-de)-1,4-benzoxazine-6-carboxylic acid, hemihydrate, 7H-Pyrido(1,2,3-de)-1,4-benzoxazine-6-carboxylic acid, 9-fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-, hydrate (2:1), (S)-, Levofloxacin in 5% Dextrose, Levofloxacin, sodium chloride, DTXCID8021060, J01MA12, S01AE05, LEVOFLOXACIN IN DEXTROSE 5% IN PLASTIC CONTAINER, 600-146-0, 7H-Pyrido(1,2,3-de)-1,4-benzoxazine-6-carboxylic Acid, 9-Fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-, (S)-, 6GNT3Y5LMF, Levofloxacin (as hemihydrate), Levofloxacin hemihydrate, Ofloxacin, (S)-, Ofloxacin S-(-)-form, (S)-(-)-Ofloxacin, MFCD00865049, Levofloxacin (Levaquin), MP-376, Levofloxacin (INN), Levaquin (TN), 7H-Pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic acid, 9-fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-, (3S)-, (3S)-9-fluoro-3-methyl-10-(4-methylpiperazin-1-yl)-7-oxo-2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid, MMV687798, (S)-9-fluoro-3-methyl-10-(4-methylpiperazin-1-yl)-7-oxo-3,7-dihydro-2H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid, LEVOFLOXACIN [INN], LFX, Levofloxacine [INN-French], Levofloxacinum [INN-Latin], Levofloxacino [INN-Spanish], DR3355, HR 355, Aeroquin, Unibiotic, Venaxan, Levofloxacin [USAN:INN:JAN], Loxof, RWJ 25213-097, (-)-(S)-9-Fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazin-yl)-7-oxo-7H-pyrido(1,2,3-de)-1,4-benzoxazine-6-carboxylic acid, SMR000466387, Cravit (TN), S-(-)-Ofloxacin, CCRIS 4074, UNII-RIX4E89Y14, Levofiexacin, Ofloxcacin, S-ofloxacin, s1940, HSDB 8028, Cravit IV, Anhydrous Ofloxacin, DR-3355: L-isomer of ofloxacin, LevofloxacinLevaquin, (S)-9-fluoro-2,3-dihydro-3-methyl-10-(4-methylpiperazin-1-yl)-7-oxo-7H-pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic acid, HR-355, MP 376, Spectrum_001719, CPD000466387, Levofloxacin (Standard), Levofloxacin (anhydrous), Levofloxacine (anhydrous), Levofloxacino (anhydrous), Spectrum2_001676, Spectrum3_000995, Spectrum4_001123, Spectrum5_001438, SCHEMBL15397, BSPBio_002689, KBioGR_001605, KBioSS_002199, (-)-(S)-9-Fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7H-pyrido(1,2,3-de)-1,4-benzoxazine-6-carboxylic acid, fluoro-methyl-(4-methylpiperazin-1-yl)-oxo-[?]carboxylic acid, MLS000759524, MLS001165709, MLS001423977, LEVOFLOXACIN [WHO-DD], SPECTRUM1504260, SPBio_001891, orb1300652, orb3141259, GTPL10911, HY-B0330R, KBio2_002199, KBio2_004767, KBio2_007335, KBio3_001909, MSK5725, HMS1922J07, HMS2051G04, HMS2090O10, HMS2093E18, HMS2232G06, Pharmakon1600-01504260, EX-A1488, HY-B0330, Levofloxacin, >=98.0% (HPLC), BDBM50366826, CCG-39093, DE-108, EBC-11226, MSK5725-100D, MSK5725-100M, NSC755604, NSC758709, OFLOXACIN S-(-)-FORM [MI], AKOS008901361, AKOS015895104, AC-7593, AL10796, DB01137, NC00094, NSC 758709, NSC-755604, NCGC00178529-01, NCGC00178529-02, NCGC00178529-03, NCGC00178529-06, (S)-9-fluoro-3-methyl-10-(4-methylpiperazin-1-yl)-7-oxo-2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid, AS-31796, SY007392, Levofloxacin Solution in DMSO, 100ug/mL, Levofloxacin, analytical reference material, SBI-0206768.P001, L0193, Levofloxacin Solution in Methanol, 100ug/mL, NS00010154, C07660, D08120, AB00171657-12, AB00171657-13, AB00171657_14, AB00171657_15, F387019, Q424193, SR-05000001999, SR-05000001999-1, BRD-K09471561-001-06-7, BRD-K09471561-001-18-2, Z1590790198, ()-(S)-9-Fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7H-pyrido[1,2,3-de]-1, ()-(S)-9-Fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7H-pyrido[1,2,3-de]-1, (2S)-7-Fluoro-2-methyl-6-(4-methylpiperazin-4-ium-1-yl)-10-oxo-4-oxa-1-azatricyclo[7.3.1.05,13]trideca-5(13),6,8,11-tetraene-11-carboxylate, (3S)-9-Fluoro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid, (S)-9-fluoro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-2,3-dihydro-7H-pyrido[1,2,3-de][1,4]-benzoxazine-6-carboxylic acid
Bioactivity: Fluoroquinolone antibiotic; bacterial DNA gyrase and topoisomerase IV inhibitor
Solubility in Different Solvents
| Solvent | Temperature [K] | Crystal form | Solubility [mg/mL] | Reference |
|---|---|---|---|---|
| 1-Butanol | 288.15 | - | 5.771 | [42] |
| 1-Butanol | 293.15 | - | 6.928 | [42] |
| 1-Butanol | 298.15 | - | 8.635 | [42] |
| 1-Butanol | 303.15 | - | 10.51 | [42] |
| 1-Butanol | 308.15 | - | 13.7 | [42] |
| 1-Butanol | 313.15 | - | 17.52 | [42] |
| 1-Butanol | 318.15 | - | 23.37 | [42] |
| 1-Butanol | 323.15 | - | 30.67 | [42] |
| 1-Butanol | 328.15 | - | 35.19 | [42] |
| 1-Propanol | 288.15 | - | 5.304 | [42] |
| 1-Propanol | 293.15 | - | 5.83 | [42] |
| 1-Propanol | 298.15 | - | 6.843 | [42] |
| 1-Propanol | 303.15 | - | 8.657 | [42] |
| 1-Propanol | 308.15 | - | 11.15 | [42] |
| 1-Propanol | 313.15 | - | 13.49 | [42] |
| 1-Propanol | 318.15 | - | 17.7 | [42] |
| 1-Propanol | 323.15 | - | 21.15 | [42] |
| 1-Propanol | 328.15 | - | 26.82 | [42] |
| Acetic acid | 298.15 | - | 372.0 | [42] |
| Acetic acid | 303.15 | - | 383.8 | [42] |
| Acetic acid | 308.15 | - | 399.1 | [42] |
| Acetic acid | 313.15 | - | 412.8 | [42] |
| Acetic acid | 318.15 | - | 427.7 | [42] |
| Acetic acid | 323.15 | - | 440.6 | [42] |
| Acetic acid | 328.15 | - | 449.7 | [42] |
| Ethanol | 288.15 | - | 3.55 | [42] |
| Ethanol | 293.15 | - | 4.909 | [42] |
| Ethanol | 298.15 | - | 6.594 | [42] |
| Ethanol | 303.15 | - | 8.22 | [42] |
| Ethanol | 308.15 | - | 10.88 | [42] |
| Ethanol | 313.15 | - | 15.43 | [42] |
| Ethanol | 318.15 | - | 19.4 | [42] |
| Ethanol | 323.15 | - | 24.77 | [42] |
| Ethanol | 328.15 | - | 31.49 | [42] |
| Ethyl acetate | 288.15 | - | 7.186 | [42] |
| Ethyl acetate | 293.15 | - | 7.799 | [42] |
| Ethyl acetate | 298.15 | - | 8.13 | [42] |
| Ethyl acetate | 303.15 | - | 9.001 | [42] |
| Ethyl acetate | 308.15 | - | 10.24 | [42] |
| Ethyl acetate | 313.15 | - | 11.64 | [42] |
| Ethyl acetate | 318.15 | - | 13.6 | [42] |
| Ethyl acetate | 323.15 | - | 17.25 | [42] |
| Ethyl acetate | 328.15 | - | 19.59 | [42] |
| Isopropanol | 288.15 | - | 2.09 | [42] |
| Isopropanol | 293.15 | - | 2.576 | [42] |
| Isopropanol | 298.15 | - | 3.01 | [42] |
| Isopropanol | 303.15 | - | 3.839 | [42] |
| Isopropanol | 308.15 | - | 4.796 | [42] |
| Isopropanol | 313.15 | - | 6.263 | [42] |
| Isopropanol | 318.15 | - | 7.531 | [42] |
| Isopropanol | 323.15 | - | 9.93 | [42] |
| Isopropanol | 328.15 | - | 12.26 | [42] |
Molecule 3D descriptors
| Descriptor | Value |
|---|---|
| PMI1 | 1094.6828 |
| PMI2 | 4613.4328 |
| PMI3 | 5431.6704 |
| NPR1 | 0.2015 |
| NPR2 | 0.8494 |
| RadiusOfGyration | 3.9260 |
| InertialShapeFactor | 0.0008 |
| Eccentricity | 0.9795 |
| Asphericity | 0.5135 |
| SpherocityIndex | 0.1610 |
| PBF | 0.7365 |